BG106851A - Calcium dicarboxylate ethers, methods of making same, and their use for the treatment of vascular disease and diabetes therewith - Google Patents
Calcium dicarboxylate ethers, methods of making same, and their use for the treatment of vascular disease and diabetes therewithInfo
- Publication number
- BG106851A BG106851A BG106851A BG10685102A BG106851A BG 106851 A BG106851 A BG 106851A BG 106851 A BG106851 A BG 106851A BG 10685102 A BG10685102 A BG 10685102A BG 106851 A BG106851 A BG 106851A
- Authority
- BG
- Bulgaria
- Prior art keywords
- treatment
- methods
- vascular disease
- making same
- diabetes
- Prior art date
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229910052791 calcium Inorganic materials 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 150000002170 ethers Chemical class 0.000 title 1
- 208000019553 vascular disease Diseases 0.000 title 1
- SDMBRCRVFFHJKR-UHFFFAOYSA-N 6-(5-carboxy-5-methylhexoxy)-2,2-dimethylhexanoic acid Chemical compound OC(=O)C(C)(C)CCCCOCCCCC(C)(C)C(O)=O SDMBRCRVFFHJKR-UHFFFAOYSA-N 0.000 abstract 1
- 208000032928 Dyslipidaemia Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17782300P | 2000-01-25 | 2000-01-25 | |
| PCT/IB2001/000026 WO2001055078A1 (en) | 2000-01-25 | 2001-01-11 | Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG106851A true BG106851A (en) | 2003-01-31 |
Family
ID=22650106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG106851A BG106851A (en) | 2000-01-25 | 2002-06-20 | Calcium dicarboxylate ethers, methods of making same, and their use for the treatment of vascular disease and diabetes therewith |
Country Status (39)
| Country | Link |
|---|---|
| EP (1) | EP1259474B1 (cs) |
| JP (1) | JP4750995B2 (cs) |
| KR (1) | KR20020073182A (cs) |
| CN (1) | CN1395555A (cs) |
| AP (1) | AP2002002587A0 (cs) |
| AR (1) | AR029436A1 (cs) |
| AT (1) | ATE431326T1 (cs) |
| AU (1) | AU2214001A (cs) |
| BG (1) | BG106851A (cs) |
| BR (1) | BR0107763A (cs) |
| CA (1) | CA2397960C (cs) |
| CO (1) | CO5261537A1 (cs) |
| CZ (1) | CZ20022474A3 (cs) |
| DE (1) | DE60138686D1 (cs) |
| DK (1) | DK1259474T3 (cs) |
| DZ (1) | DZ3239A1 (cs) |
| EA (1) | EA004862B1 (cs) |
| EE (1) | EE200200404A (cs) |
| ES (1) | ES2324281T3 (cs) |
| GE (1) | GEP20053428B (cs) |
| GT (1) | GT200100015A (cs) |
| HN (1) | HN2001000011A (cs) |
| HU (1) | HUP0204422A3 (cs) |
| IL (1) | IL150541A0 (cs) |
| IS (1) | IS6442A (cs) |
| MA (1) | MA26867A1 (cs) |
| MX (1) | MXPA02007223A (cs) |
| NO (1) | NO20023526L (cs) |
| NZ (1) | NZ519550A (cs) |
| OA (1) | OA12166A (cs) |
| PA (1) | PA8510601A1 (cs) |
| PE (1) | PE20011064A1 (cs) |
| PL (1) | PL357076A1 (cs) |
| SK (1) | SK10622002A3 (cs) |
| SV (1) | SV2002000290A (cs) |
| TN (1) | TNSN01013A1 (cs) |
| UY (1) | UY26550A1 (cs) |
| WO (1) | WO2001055078A1 (cs) |
| ZA (1) | ZA200205880B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1045691T1 (en) * | 1997-12-12 | 2005-04-30 | Warner-Lambert Company Llc | Statin-carboxyalkylether combinations |
| JP2006501238A (ja) * | 2002-08-22 | 2006-01-12 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 骨関節炎を治療する方法 |
| US7816405B2 (en) | 2005-04-19 | 2010-10-19 | Eisai R&D Management Co., Ltd. | Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof |
| JPWO2006115130A1 (ja) * | 2005-04-19 | 2008-12-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ビス［（２ｓ）−３−［３−［（２ｓ）−３−（４−クロロ−２−シアノフェノキシ）−２−フルオロプロポキシ］フェニル］−２−イソプロポキシプロピオン酸］カルシウム及びその中間体 |
| EP3218349A2 (en) * | 2014-11-14 | 2017-09-20 | Gemphire Therapeutics Inc. | Processes and intermediates for preparing , -dicarboxylic acid-terminated dialkane ethers |
| EP3612171A4 (en) | 2017-04-18 | 2020-10-21 | Gemphire Therapeutics Inc. | GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME |
| JP2022505033A (ja) * | 2018-10-18 | 2022-01-14 | ジェムフィアー セラピューティクス インコーポレイテッド | ゲムカベン、薬学的に許容されるその塩、その組成物、およびその使用方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648387A (en) | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
| NZ503982A (en) | 1997-12-12 | 2002-03-28 | Warner Lambert Co | Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus |
-
2001
- 2001-01-11 NZ NZ519550A patent/NZ519550A/en unknown
- 2001-01-11 DZ DZ013239A patent/DZ3239A1/fr active
- 2001-01-11 EP EP01900037A patent/EP1259474B1/en not_active Expired - Lifetime
- 2001-01-11 BR BR0107763-5A patent/BR0107763A/pt not_active IP Right Cessation
- 2001-01-11 IL IL15054101A patent/IL150541A0/xx unknown
- 2001-01-11 AP APAP/P/2002/002587A patent/AP2002002587A0/en unknown
- 2001-01-11 AU AU22140/01A patent/AU2214001A/en not_active Abandoned
- 2001-01-11 DK DK01900037T patent/DK1259474T3/da active
- 2001-01-11 HU HU0204422A patent/HUP0204422A3/hu unknown
- 2001-01-11 GE GE4872A patent/GEP20053428B/en unknown
- 2001-01-11 CZ CZ20022474A patent/CZ20022474A3/cs unknown
- 2001-01-11 WO PCT/IB2001/000026 patent/WO2001055078A1/en not_active Ceased
- 2001-01-11 AT AT01900037T patent/ATE431326T1/de not_active IP Right Cessation
- 2001-01-11 PL PL01357076A patent/PL357076A1/xx not_active Application Discontinuation
- 2001-01-11 DE DE60138686T patent/DE60138686D1/de not_active Expired - Lifetime
- 2001-01-11 SK SK1062-2002A patent/SK10622002A3/sk not_active Application Discontinuation
- 2001-01-11 OA OA1200200226A patent/OA12166A/en unknown
- 2001-01-11 JP JP2001555021A patent/JP4750995B2/ja not_active Expired - Fee Related
- 2001-01-11 EA EA200200641A patent/EA004862B1/ru not_active IP Right Cessation
- 2001-01-11 MX MXPA02007223A patent/MXPA02007223A/es active IP Right Grant
- 2001-01-11 CN CN01804045A patent/CN1395555A/zh active Pending
- 2001-01-11 CA CA002397960A patent/CA2397960C/en not_active Expired - Lifetime
- 2001-01-11 EE EEP200200404A patent/EE200200404A/xx unknown
- 2001-01-11 KR KR1020027009519A patent/KR20020073182A/ko not_active Ceased
- 2001-01-11 ES ES01900037T patent/ES2324281T3/es not_active Expired - Lifetime
- 2001-01-22 SV SV2001000290A patent/SV2002000290A/es not_active Application Discontinuation
- 2001-01-22 UY UY26550A patent/UY26550A1/es not_active Application Discontinuation
- 2001-01-23 AR ARP010100284A patent/AR029436A1/es unknown
- 2001-01-23 GT GT200100015A patent/GT200100015A/es unknown
- 2001-01-23 PA PA20018510601A patent/PA8510601A1/es unknown
- 2001-01-24 CO CO01005267A patent/CO5261537A1/es not_active Application Discontinuation
- 2001-01-24 PE PE2001000076A patent/PE20011064A1/es not_active Application Discontinuation
- 2001-01-24 TN TNTNSN01013A patent/TNSN01013A1/fr unknown
- 2001-01-24 HN HN2001000011A patent/HN2001000011A/es unknown
-
2002
- 2002-06-20 BG BG106851A patent/BG106851A/xx unknown
- 2002-06-25 IS IS6442A patent/IS6442A/is unknown
- 2002-07-22 MA MA26735A patent/MA26867A1/fr unknown
- 2002-07-23 ZA ZA200205880A patent/ZA200205880B/xx unknown
- 2002-07-24 NO NO20023526A patent/NO20023526L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE268179T1 (de) | Verwendung von substituierten imidazo (1,2- a)pyridin-, -pyrimidin- und -pyrazin-3-yl-amin- derivaten zur herstellung von medikamenten zur nos-inhibierung | |
| YU70901A (sh) | Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena | |
| AP1635A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease. | |
| DE69522947D1 (en) | Phenylxanthin-derivate | |
| PT711282E (pt) | Compostos inibidores de pde iv e de fnt | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| EP1365762A4 (en) | PROCESS FOR INCREASING THE LEPTIN MIRRORS USING NICOTINIC ACID COMPOUNDS | |
| WO2005016261A3 (en) | Aripiprazole and haloperidol pamoate salts | |
| IL190905A0 (en) | 4-alkoxy cyclohexane-1-amino carboxylic acids and processes for their prepatation | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| TW200504009A (en) | Novel diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use | |
| MY128241A (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
| PL1725536T3 (pl) | Pochodne imidazoliny mające czynność CB1-antagonistyczną | |
| PL344056A1 (en) | Piperididinyl and n-amidinopiperidinyl derivatives | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| AP2002002587A0 (en) | Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith. | |
| IL166103A0 (en) | Pyrrolidine derivatives and their use | |
| BRPI0417179A (pt) | gentisato de amlodipina, método de preparar o mesmo e composição farmacêutica para tratamento de doenças cardiovasculares | |
| EA199900675A2 (ru) | Полиморф моногидрата зополрестата | |
| DE60139409D1 (de) | Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen | |
| MXPA05012743A (es) | Composicion de limpieza mejorada. | |
| DE69930621D1 (de) | Medizinische zusammensetzungen zur unmittelbaren freisetzung bei oraler anwendung | |
| EP1200432A4 (en) | AMIDO SPIROPIPERIDINE PROMOVES THE RELEASE OF GROWTH HORMONES | |
| WO2001081298A3 (en) | Cyclic carboxylic acids as integrin antagonists | |
| IL149544A0 (en) | N-ACYLPYRROLIDIN-2-YLALKYLBENZAMIDINE DERIVATIVES AS INHIBITORS OF FACTOR Xa |